ATE445393T1 - Tablette mit gefärbtem kern - Google Patents

Tablette mit gefärbtem kern

Info

Publication number
ATE445393T1
ATE445393T1 AT04729172T AT04729172T ATE445393T1 AT E445393 T1 ATE445393 T1 AT E445393T1 AT 04729172 T AT04729172 T AT 04729172T AT 04729172 T AT04729172 T AT 04729172T AT E445393 T1 ATE445393 T1 AT E445393T1
Authority
AT
Austria
Prior art keywords
core
coating
tablet
colored core
colouring agent
Prior art date
Application number
AT04729172T
Other languages
English (en)
Inventor
Guy Vergnault
Pascal Grenier
Christophe Dragan
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Application granted granted Critical
Publication of ATE445393T1 publication Critical patent/ATE445393T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
AT04729172T 2003-04-24 2004-04-23 Tablette mit gefärbtem kern ATE445393T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0309343 2003-04-24
PCT/IB2004/001702 WO2004093850A1 (en) 2003-04-24 2004-04-23 Tablet with coloured core

Publications (1)

Publication Number Publication Date
ATE445393T1 true ATE445393T1 (de) 2009-10-15

Family

ID=33306520

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04729172T ATE445393T1 (de) 2003-04-24 2004-04-23 Tablette mit gefärbtem kern

Country Status (9)

Country Link
US (1) US20070148229A1 (de)
EP (1) EP1615626B1 (de)
JP (1) JP4908200B2 (de)
AT (1) ATE445393T1 (de)
CY (1) CY1109726T1 (de)
DE (1) DE602004023597D1 (de)
DK (1) DK1615626T3 (de)
ES (1) ES2335008T3 (de)
WO (1) WO2004093850A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004231362B2 (en) 2003-04-24 2009-11-12 Jagotec Ag Delayed release tablet with defined core geometry
CA2533150C (en) * 2003-07-25 2013-03-12 Warner Chilcott Company, Inc. A doxycycline metal complex in a solid dosage form
KR101363563B1 (ko) * 2004-09-10 2014-02-14 자고텍 아게 활성성분의 부위 및 시간 제어적 위장관 방출 정제
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
MX2009001248A (es) 2006-08-03 2009-02-11 Nitec Pharma Ag Tratamiento con glucocorticoide de liberacion prolongada de enfermedad reumatoide.
AU2010207740B2 (en) * 2009-01-26 2016-06-16 Nitec Pharma Ag Delayed-release glucocorticoid treatment of asthma
NZ582836A (en) * 2009-01-30 2011-06-30 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
JP5818219B2 (ja) * 2012-05-14 2015-11-18 塩野義製薬株式会社 ６，７−不飽和−７−カルバモイルモルヒナン誘導体含有製剤

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB874586A (en) * 1957-10-28 1961-08-10 Upjohn Co Improvements in or relating to therapeutic compositions and the manufacture thereof
GB860708A (en) * 1958-06-23 1961-02-08 Sterling Drug Inc Medicinal tablets comprising 4-aminoquinoline-type drugs and salicylates
US3048526A (en) 1958-08-04 1962-08-07 Wander Company Medicinal tablet
GB972128A (en) * 1960-01-21 1964-10-07 Wellcome Found Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
BE629982A (de) * 1962-04-06
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
DE3930770A1 (de) * 1989-09-14 1991-03-28 Wolfgang F Dr Schoener Implantierbare katheter aus medizinisch vertraeglichem elastischen kunststoff
US5310578A (en) * 1990-09-17 1994-05-10 Merck Patent Gesellschaft Deposition of cosmetically functional material onto pigments and fillers
DE4100920A1 (de) * 1991-01-15 1992-07-16 Degussa Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
JPH0672861A (ja) * 1992-07-09 1994-03-15 Takeda Chem Ind Ltd 着色固形製剤
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
WO1994008589A1 (en) * 1992-10-09 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Treatment of systemic lupus erythematosus with dehydroepiandrosterone
TW272942B (de) * 1993-02-10 1996-03-21 Takeda Pharm Industry Co Ltd
JPH06256171A (ja) * 1993-03-04 1994-09-13 Shin Etsu Chem Co Ltd セルロース系腸溶性コーチング剤
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
US5709880A (en) * 1995-07-10 1998-01-20 Buckman Laboratories International, Inc. Method of making tabletized ionene polymers
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US5792476A (en) * 1996-12-19 1998-08-11 Abigo Medical Ab Sustained release glucocorticoid pharmaceutical composition
US6365185B1 (en) * 1998-03-26 2002-04-02 University Of Cincinnati Self-destructing, controlled release peroral drug delivery system
GB9905898D0 (en) * 1999-03-15 1999-05-05 Darwin Discovery Ltd Controlled-dose formulation
JP2001017121A (ja) * 1999-07-05 2001-01-23 Anpureenu Europe:Kk 被覆粒体及びその製造方法
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
US6720327B2 (en) * 2000-09-27 2004-04-13 Pharmacia Corporation Lactone integrin antagonists
US6620439B1 (en) * 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
JP2002212104A (ja) * 2000-11-17 2002-07-31 Takeda Chem Ind Ltd タルク／硫酸バリウム含有製剤
HUP0501071A3 (en) * 2001-03-13 2007-06-28 Penwest Pharmaceutical Co Chronotherapeutic dosage forms
EP1245227A1 (de) * 2001-03-31 2002-10-02 Jagotec Ag Pharmazeutische, im Magen aufschwimmende Tablette für die programmierte Freisetzung des Wirkstoffes und Verfahren zur Herstellung des in der Tablette enthaltenen schwimmfähigen Materials
IN191028B (de) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
NZ532568A (en) * 2001-09-28 2005-07-29 Mcneil Ppc Inc Modified release dosage forms
JP4336074B2 (ja) * 2001-11-15 2009-09-30 三菱商事フードテック株式会社 色調および食感が良好な硬質糖衣錠剤
AU2004231362B2 (en) * 2003-04-24 2009-11-12 Jagotec Ag Delayed release tablet with defined core geometry
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum

Also Published As

Publication number Publication date
EP1615626A1 (de) 2006-01-18
JP4908200B2 (ja) 2012-04-04
US20070148229A1 (en) 2007-06-28
EP1615626B1 (de) 2009-10-14
ES2335008T3 (es) 2010-03-18
DK1615626T3 (da) 2010-02-08
JP2006524230A (ja) 2006-10-26
DE602004023597D1 (de) 2009-11-26
WO2004093850A1 (en) 2004-11-04
CY1109726T1 (el) 2014-09-10

Similar Documents

Publication Publication Date Title
CY1109726T1 (el) Δισκιο εγχρωμου πυρηνα
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
ATE251449T1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
HUP0203623A2 (hu) Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
DOP2001000229A (es) Forma de dosificación de fármaco activada por hidrogel
HK1079455A1 (en) Medical active agent patch optically less visible on skin
ATE286715T1 (de) Gastrointestinale an der mucosa haftende pharmazeutische zusammensetzung
AR021391A1 (es) Inhaladores presurizados de dosis medidas (mdi) y su uso.
PA8458101A1 (es) Formas de dosificacion farmaceuticas solidas
AR064901A2 (es) Una pelicula consumible adaptada para disolverse en la boca de un consumidor
HUP0300530A2 (hu) Hidrofil/lipofil polimer mátrix adagolási kiszerelés
UY27186A1 (es) Formulación farmacéutica
ATE430557T1 (de) Liposomen
ATE311858T1 (de) Dosierungsform mit flüssiger formulierung
ES2196620T3 (es) Formulacion de liberacion prolongada que contiene venlafaxina.
DE60128263D1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
PT994887E (pt) Glicosidos modificados composicoes que compreendem os mesmos e metodos para a sua utilizacao
BRPI0012553B8 (pt) pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso
AR020205A1 (es) Formulacion efervescente esterilizante.
DE602004009060D1 (de) Kissen zur hautreinigung und hautbefeuchtung
AR008025A1 (es) Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina
IT1299969B1 (it) Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties